Werewolf Therapeutics, Inc.
HOWL
Positions held
Your positionsHOWL isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $44.23M | Enterprise value | $22.24M | Trailing P/E | — | Forward P/E | -1.54 |
| PEG | — | Price / book | 2.72 | Beta | 0.51 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | -24.7% | Operating margin | 40.7% |
| Profit margin | -1.6% | ROE | -119.9% | ROA | -27.4% | Debt / equity | — |
| Current ratio | 2.91 | Free cash flow | -$12.23M | Analyst recommendation | none | Mean target | $7.00 |
| 52w high | $1.94 | 52w low | $0.27 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $21.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | 34.1% | — | — | — | — | — |
| Net income | $3.7M | -$13.5M | -$8.4M | -$16.4M | -$18.0M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | $7.2M | -$13.3M | -$9.4M | -$15.7M | -$17.5M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $1.9M | $19.9M | $16.4M | — |
| Op margin | — | -3904.2% | -203.1% | -341.8% | — |
| Net income | -$60.8M | -$70.5M | -$37.4M | -$53.8M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$60.7M | -$73.6M | -$40.5M | -$56.1M | — |
Headlines — watch
• [WARN · fundamentals] JAZZ Q2 Earnings Miss, Sales Beat, Stock Jumps on Raised '26 View
News
2026-10-07 · HALO Expands ENHANZE Collaboration & Licensing Deal With ARGX
2026-08-26 · 1 Penny Stock That Could Howl Its Way to the Top After a $150 Million Funding Boost
2026-08-21 · Little-Known HOWL Stock Skyrockets 100% on Biotech Merger News
2026-08-21 · Sector Update: Healthcare Stocks Advance in Afternoon Trading
2026-08-21 · BC-Most Active Stocks
2026-08-21 · Werewolf Therapeutics shares surge 120% after Ambros merger and $150 million financing
2026-08-21 · Sector Update: Healthcare Stocks Edge Higher Pre-Bell Friday
2026-08-21 · Werewolf Therapeutics to Merge With Ambros Therapeutics in All-Stock Deal
2026-08-21 · Top Premarket Gainers
2026-08-04 · JAZZ Q2 Earnings Miss, Sales Beat, Stock Jumps on Raised '26 View
Price (daily)
Full chart · RSI · MACD · patterns